1. Home
  2. RGNX vs ALRS Comparison

RGNX vs ALRS Comparison

Compare RGNX & ALRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo REGENXBIO Inc.

RGNX

REGENXBIO Inc.

HOLD

Current Price

$7.45

Market Cap

793.5M

Sector

Health Care

ML Signal

HOLD

Logo Alerus Financial Corporation

ALRS

Alerus Financial Corporation

HOLD

Current Price

$31.99

Market Cap

831.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGNX
ALRS
Founded
2008
1879
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
793.5M
831.8M
IPO Year
2015
2019

Fundamental Metrics

Financial Performance
Metric
RGNX
ALRS
Price
$7.45
$31.99
Analyst Decision
Strong Buy
Hold
Analyst Count
8
6
Target Price
★ $28.75
$25.40
AVG Volume (30 Days)
★ 1.1M
125.2K
Earning Date
05-05-2026
04-29-2026
Dividend Yield
N/A
★ 3.26%
EPS Growth
★ 18.08
N/A
EPS
N/A
★ 1.70
Revenue
★ $10,393,000.00
N/A
Revenue This Year
$51.21
$38.42
Revenue Next Year
$19.08
$4.68
P/E Ratio
★ N/A
$18.86
Revenue Growth
★ 126.48
N/A
52 Week Low
$5.46
$20.31
52 Week High
$16.19
$34.40

Technical Indicators

Market Signals
Indicator
RGNX
ALRS
Relative Strength Index (RSI) 34.34 39.87
Support Level $5.67 $30.13
Resistance Level $11.43 $32.64
Average True Range (ATR) 0.45 0.67
MACD -0.06 -0.13
Stochastic Oscillator 12.07 23.33

Price Performance

Historical Comparison
RGNX
ALRS

About RGNX REGENXBIO Inc.

Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.

About ALRS Alerus Financial Corporation

Alerus Financial Corp is a financial holding company registered in the United States. The company operates in four segments: Banking, Retirement & Benefit Services, Wealth Management, and others. The company provides various banking services such as checking, debit cards, savings, current deposits, loans and advances, online banking, mobile banking, private banking, payment solutions, and other business products. Additionally, the company provides mortgage loans, retirement planning solutions, individual retirement accounts, retirement plan advisory services and wealth management services, including retirement plans, and fiduciary services. The company's revenue mainly consists of interest income, commission, management fees, and other income.

Share on Social Networks: